TCM
AGN

Triarii Capital Management’s Allergan plc AGN Stock Holding History

Triarii Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$6.09M Hold
32,000
– – 6.23% 7
2018
Q2 		$5.33M Hold
32,000
– – 4.98% 10
2018
Q1 		$5.38M Hold
32,000
– – 6.22% 6
2017
Q4 		$5.24M Buy
+32,000
New +$5.74M 5.7% 8

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Triarii Capital Management's AGN Position: Q3 2018 in Review

Triarii Capital Management held its Allergan plc (AGN) position steady in Q3 2018 at 32,000 shares worth $6.09M. The position accounts for 6.23% of the portfolio, ranked #7.

Triarii Capital Management first reported a position in AGN in Q4 2017 and has held it in 4 quarters since. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Triarii Capital Management held 32,000 shares of Allergan plc worth $6.09M as of Q3 2018.
  • Triarii Capital Management left its Allergan plc share count unchanged in Q3 2018.
  • Allergan plc made up 6.23% of Triarii Capital Management's portfolio in Q3 2018, its #7 holding.
  • Triarii Capital Management first reported a position in Allergan plc in Q4 2017 and has held it in 4 quarters since.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Triarii Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.